Cardiac manifestations of PRKAG2 mutation
Abstract Background The Protein Kinase AMP-Activated Non-Catalytic Subunit Gamma 2 (PRKAG2) cardiac syndrome is characterized by glycogen accumulation in the cardiac tissue. The disease presents clinically with hypertrophic cardiomyopathy (HCM), and it is often associated with conduction abnormaliti...
Saved in:
Main Authors: | Pooya Banankhah (Author), Gregory A. Fishbein (Author), Anthony Dota (Author), Reza Ardehali (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PRKAG2 mutation: An easily missed cardiac specific non-lysosomal glycogenosis
by: Varun Aggarwal, et al.
Published: (2015) -
A Case Series on Cardiac and Skeletal Involvement in Two Families with PRKAG2 Mutations
by: Anita Sri, et al.
Published: (2019) -
Left ventricular non-compaction cardiomyopathy associated with the PRKAG2 mutation
by: Jing Zhang, et al.
Published: (2022) -
Novel PRKAG2 variant presenting as liver cirrhosis: report of a family with 2 cases and review of literature
by: Zahra Beyzaei, et al.
Published: (2021) -
Direct Cardiac Reprogramming: Progress and Promise
by: James L. Engel, et al.
Published: (2018)